Altered Ca2-homeostasis of cisplatin-treated and low level resistant non-small-cell and small-cell lung cancer cells

Cellular Oncology

Volumn 31, Issue 4, 2009, Pages 301-315

  Schrödl, Kathrin ^a   Oelmez, Hamza ^a   Edelmann, Martin ^a   Huber, Rudolf Maria ^a   Bergner, Albrecht ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Calcium; Cisplatin; IP 3R; Lung cancer; SERCA

Indexed keywords

BETA ACTIN; CALCIUM; CALRETICULIN; CISPLATIN; ESTROGEN RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SMALL INTERFERING RNA;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; CANCER PATIENT; CANCER RESISTANCE; CELL CLONE; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

CALCIUM; CARCINOMA, BRONCHOGENIC; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LUNG NEOPLASMS;

EID: 68149101187     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/495797     Document Type: Article

References (50)

1. A.J. Alberg, J.G. Ford and J.M. Samet, Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition), Chest 132(Suppl. 3) (2007), 29S-55S.
2. A. Alt, K. Lammens, C. Chiocchini, A. Lammens, J.C. Pieck, D. Kuch, K.P. Hopfner and T. Carell, Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta, Science 318(5852) (2007), 967-970.
3. J. Beane, P. Sebastiani, G. Liu, J.S. Brody, M.E. Lenburg and A. Spira, Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression, Genome Biol. 8(9) (2007), R201.
4. 2+-signaling in airway smooth muscle cells is altered in T-bet knock-out mice, Respir. Res. 7 (2006), 33.
5. M.J. Berridge, M.D. Bootman and H.L. Roderick, Calcium signalling: dynamics, homeostasis and remodelling, Nat. Rev. Mol. Cell Biol. 4(7) (2003), 517-529.
6. I. Bezprozvanny, The inositol 1,4,5-trisphosphate receptors, Cell Calcium 38(3/4) (2005), 261-272.
7. D. Boehning, R.L. Patterson, L. Sedaghat, N.O. Glebova, T. Kurosaki and S.H. Snyder, Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis, Nat. Cell Biol. 5(12) (2003), 1051-1061.
8. J.P. Brouland, R Gelebart, T. Kovacs, J. Enouf, J. Grossmann and B. Papp, The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the mul-tistep process of colon carcinogenesis, Am. J. Pathol. 167(1) (2005), 233-242.
9. H. Burger, K. Nooter, A.W. Boersma, C.J. Kortland and G. Stoter, Lack of correlation between cisplatin-induced apop-tosis, p53 status and expression of Bcl-2 family proteins in tes-ticular germ cell tumour cell lines, Int. J. Cancer 73(4) (1997), 592-599.
10. C. Camello, R. Lomax, O.H. Petersen and A.V. Tepikin, Cal-cium leak from intracellular stores - the enigma of calcium sig-nalling, Cell Calcium 32(5/6) (2002), 355-361.
11. 2++ concentrations determine the extent and the morpholog-ical type of apoptosis, respectively, Ann. N. Y. Acad. Sci. 1010 (2003), 74-77.
12. J.S. Chen, N. Agarwal and K. Mehta, Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular cal-cium pools, Breast Cancer Res. Treat. 71(3) (2002), 237-247.
13. R. Chen, I. Valencia, F. Zhong, K.S. McColl, H.L. Roderick, M.D. Bootman, M.J. Berridge, S.J. Conway, A.B. Holmes, G.A. Mignery, P. Velez and C.W. Distelhorst, Bcl-2 function-ally interacts with inositol 1,4,5-trisphosphate receptors to reg-ulate calcium release from the ER in response to inositol 1,4,5-trisphosphate, J. Cell Biol. 166(2) (2004), 193-203.
14. F.Y. Chung, S.R. Lin, C.Y. Lu, CS. Yeh, F.M. Chen, J.S. Hsieh, T.J. Huang and J.Y. Wang, Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer, Am. J. Surg. Pathol. 30(8) (2006), 969-974.
15. D.E. Clapham, Calcium, signaling, Cell 131(6) (2007), 10471058.
16. A. Crepin, G. Bidaux, F. Vanden Abeele, E. Dewailly, V. Gof-fin, N. Prevarskaya and C. Slomianny, Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum content due to SERCA 2b over-expression, Biochem. J. 401(1) (2007), 49-55.
17. F.E. de Jongh, J. Verweij, W.J. Loos, R. de Wit, M.J. de Jonge, A.S. Planting, K. Nooter, G. Stoter and A. Sparreboom, Body-surface area-based dosing does not increase accuracy of pre-dicting cisplatin exposure, J. Clin. Oncol. 19(17) (2001), 3733-3739.
18. N. Demaurex and C. Distelhorst, Cell biology. Apoptosis - the calcium connection, Science 300(5616) (2003), 65-67.
19. A. Deniaud, E.D. Sharaf, E. Maillier, D. Poncet, G. Kroemer, C. Lemaire and C. Brenner, Endoplasmic reticulum stress in-duces calcium-dependent permeability transition, mitochondr-ial outer membrane permeabilization and apoptosis, Oncogene 27(3) (2008), 285-299.
20. A. Eastman, Reevaluation of interaction of cis-dichloro(ethylenediamine) platinum(II) with DNA, Biochemistry 25(13) (1986), 3912-3915.
21. 2+) ATPase type 2 downregulated in human oral squamous cell carcinoma, Int. J. Cancer 110(2) (2004), 225-231.
22. J.K. Ghali, W.B. Smith, G. Torre-Amione, W. Haynos, B.K. Rayburn, A. Amato, D. Zhang, D. Cowart, G. Valentini, R Carminati and M. Gheorghiade, A phase 1.-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic pa-rameters in patients with chronic heart failure with reduced sys-tolic function, Am. J. Cardiol. 99(2A) (2007), 47A-56A.
23. G. Hajnoczky, G. Csordas, M. Madesh and P. Pacher, Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals, Cell Calcium 28(5/6) (2000), 349-363.
24. J. Heighway, D.C Betticher, P.R. Hoban, H.J. Altermatt and R. Cowen, Coamplification in tumors of KRAS2, type 2 inos-itol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG, Genomics 35(1) (1996), 207-214.
25. S. Humez, G. Legrand, F. Vanden Abeele, M. Monet, R Marchetti, G. Lepage, A. Crepin, E. Dewailly, F. Wuytack and N. Prevarskaya, Role of endoplasmic reticulum calcium content in prostate cancer cell growth regulation by IGF and TNFalpha, J. Cell. Physiol. 201(2) (2004), 201-213.
26. 2+ release and beyond, Apoptosis 12(5) (2007), 951-968.
27. A.F. Kabore, J.B. Johnston and S.B. Gibson, Changes in the apoptotic and survival signaling in cancer cells and their poten-tial therapeutic implications, Curr. Cancer Drug Targets 4(2) (2004), 147-163.
28. B. Korosec, D. Glavac, T. Rott and M. Ravnik-Glavac, Alter-ations in the ATP2A2 gene in correlation with colon and lung cancer, Cancer Genet. Cytogen. 171(2) (2006), 105-111.
29. 2+-ATPases 2B involvement in human prostate cancer cell growth control, J. Biol. Chem. 276(50) (2001), 47608-47614.
30. X. Liang and Y. Huang, Intracellular free calcium concentra-tion and cisplatin resistance in human lung adenocarcinoma A549 cells, Biosci. Rep. 20(3) (2000), 129-138.
31. L. Lipskaia, J.S. Hulot and A.M. Lompre, Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation, Pflugers Arch. 457(3) (2009), 673-685.
32. L. Lipskaia, H. Ly, Y. Kawase, R. Hajjar and A.M. Lompre, Treatment of heart failure by calcium cycling genetherapy, Fu-ture Cardiol. 3 (2008), 413-423.
33. A. Mandic, J. Hansson, S. Linder and M.C. Shoshan, Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling, J. Biol. Chem. 278(11) (2003), 9100-9106.
34. M.P. Mattson and S.L. Chan, Calcium orchestrates apoptosis, Nat. Cell Biol. 5(12) (2003), 1041-1043.
35. 2+ transport, Nat. Rev. Cancer 7(7) (2007), 519-530.
36. S. Orrenius, B. Zhivotovsky and R Nicotera, Regulation of cell death: the calcium-apoptosis link, Nat. Rev. Mol. Cell Biol. 4(7) (2003), 552-565.
37. 2+-ATPases in thy-roid and its down-regulation following neoplastic transforma-tion, J. Mol. Endocrinol. 30(3) (2003), 399-409.
38. S. Padar, C. van Breemen, D.W. Thomas, J.A. Uchizono, J.C. Livesey and R. Rahimian, Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone, Br. J. Pharmacol. 142(2) (2004), 305-316.
39. 2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility, Cancer Res. 65(19) (2005), 8655-8661.
40. 2+ homeostasis in apoptotic resistance of prostate cancer cells, Biochem. Biophys. Res. Commun. 322(4) (2004), 1326-1335.
41. C. Sakakura, A. Hagiwara, K. Fukuda, K. Shimomura, T. Tak-agi, S. Kin, Y. Nakase, J. Fujiyama, K. Mikoshiba, Y. Okazaki and H. Yamagishi, Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dis-semination of gastric cancers, Anticancer Res. 23(5A) (2003), 3691-3697.
42. A. Spira, J. Beane, V. Shah, G. Liu, F. Schembri, X. Yang, J. Palma and J.S. Brody, Effects of cigarette smoke on the hu-man airway epithelial cell transcriptome, Proc. Natl. Acad. Sci. USA 101(27) (2004), 10143-10148.
43. 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis, Br. J. Pharmacol. 151(8) (2007), 1176-1186.
44. D.J. Stewart, Mechanisms of resistance to cisplatin and carbo-platin, Crit. Rev. Oncol. Hematol. 63(1) (2007), 12-31.
45. 2+-leak channel: cell biological and pathological consequences, Biol. Cell 98(1) (2006), 1-14.
46. T. Tsunoda, H. Koga, A. Yokomizo, K. Tatsugami, M. Eto, J. Inokuchi, A. Hirata, K. Masuda, K. Okumura and S. Naito, Inositol 1,4,5-trisphosphate (IP3) receptor type 1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines, Oncogene 24(8) (2005), 1396-1402.
47. A. Vaisman, M. Varchenko, I. Said and S.G. Chaney, Cell cycle changes associated with formation of Pt-DNA adducts in hu-man ovarian carcinoma cells with different cisplatin sensitivity, Cytometry 27(1) (1997), 54-64.
48. 2+ homeostasis and apoptotic resis-tance of neuroendocrine-differentiated prostate cancer cells, Cell Death Differ. 11(3) (2004), 321-330.
49. F. Wuytack, L. Raeymaekers and L. Missiaen, Molecular phys-iology of the SERCA and SPCA pumps, Cell Calcium 32(5/6) (2002), 279-305.
50. 2+ handling in heart failure, J. Clin. Invest. 115(3) (2005), 556-564.